MedPath

R-33 DPS

R-33 DPS

Discontinued
DIN Number

02090325

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

dr reckeweg canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02090325
AIG Number0626041001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormDrops
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (6)

BELLADONNAActive
Strength: 30 D / 10 ML
Monograph: BELLADONNA
BUFO VULGARISActive
Strength: 200 D / 10 ML
Monograph: BUFO VULGARIS
COPPERActive
Strength: 12 D / 10 ML
Monograph: COPPER
PULSATILLAActive
Strength: 30 D / 10 ML
Monograph: PULSATILLA
SILICON DIOXIDEActive
Strength: 30 D / 10 ML
Monograph: SILICON DIOXIDE
ZINCActive
Strength: 12 D / 10 ML
Monograph: ZINC

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.